Vernillet L - Search Results

1

Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A.

Gardier AM, Mathé D, Guédeney X, Barré J, Benvenutti C, Navarro N, Vernillet L, Loisance D, Cachera JP, Jacotot B, et al. Gardier AM, et al. Among authors: vernillet l. Ther Drug Monit. 1993 Aug;15(4):274-80. doi: 10.1097/00007691-199308000-00003. Ther Drug Monit. 1993. PMID: 8236361

2

In vitro binding and partitioning of irinotecan (CPT-11) and its metabolite, SN-38, in human blood.

Combes O, Barré J, Duché JC, Vernillet L, Archimbaud Y, Marietta MP, Tillement JP, Urien S. Combes O, et al. Among authors: vernillet l. Invest New Drugs. 2000 Feb;18(1):1-5. doi: 10.1023/a:1006379730137. Invest New Drugs. 2000. PMID: 10830136

3

Lack of effect of isradipine on cyclosporin pharmacokinetics.

Vernillet L, Bourbigot B, Codet JP, Le Saux L, Moal MC, Morin JF. Vernillet L, et al. Fundam Clin Pharmacol. 1992;6(8-9):367-74. doi: 10.1111/j.1472-8206.1992.tb00132.x. Fundam Clin Pharmacol. 1992. PMID: 1292968

4

Lack of effect of spiramycin on cyclosporin pharmacokinetics.

Vernillet L, Bertault-Peres P, Berland Y, Barradas J, Durand A, Olmer M. Vernillet L, et al. Br J Clin Pharmacol. 1989 Jun;27(6):789-94. doi: 10.1111/j.1365-2125.1989.tb03441.x. Br J Clin Pharmacol. 1989. PMID: 2667601 Free PMC article. Clinical Trial.

5

Noninterchangeability of specific radioimmunoassay and monoclonal antibody fluorescent polarization immunoassay in cyclosporine measurements.

Pape D, Vernillet L, Bellissant E, Bentue-Ferrer D, Allain H. Pape D, et al. Among authors: vernillet l. Fundam Clin Pharmacol. 1996;10(5):484-9. doi: 10.1111/j.1472-8206.1996.tb00604.x. Fundam Clin Pharmacol. 1996. PMID: 8902552

6

Cyclosporine disposition and metabolite profiles in renal transplant patients receiving a microemulsion formulation.

Kovarik JM, Vernillet L, Mueller EA, Freiburghaus R, Niederberger W, Kutz K. Kovarik JM, et al. Among authors: vernillet l. Ther Drug Monit. 1994 Oct;16(5):519-25. doi: 10.1097/00007691-199410000-00014. Ther Drug Monit. 1994. PMID: 7846753 Clinical Trial.

7

Ocular distribution of cyclosporin A (Sandimmun) following systemic and topical administration to rabbits.

Vernillet L, Lundh RL, Acezat-Mispelter F, Goizel C, Humbert H, Pouliquen Y. Vernillet L, et al. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:150-8. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820870

8

[Pharmacokinetics of cyclosporin A in patients with nephrotic syndrome].

Moulin B, Vernillet L, Dadoun C, Le Bigot JF, Godin M, Fillastre JP. Moulin B, et al. Among authors: vernillet l. Nephrologie. 1989;10(1):17-22. Nephrologie. 1989. PMID: 2716940 French.

9

Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatin.

Mathijssen RH, van Alphen RJ, de Jonge MJ, Verweij J, de Bruijn P, Loos WJ, Nooter K, Vernillet L, Stoter G, Sparreboom A. Mathijssen RH, et al. Among authors: vernillet l. Anticancer Drugs. 1999 Jan;10(1):9-16. doi: 10.1097/00001813-199901000-00002. Anticancer Drugs. 1999. PMID: 10194542 Clinical Trial.

10

Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans.

Santos A, Zanetta S, Cresteil T, Deroussent A, Pein F, Raymond E, Vernillet L, Risse ML, Boige V, Gouyette A, Vassal G. Santos A, et al. Among authors: vernillet l. Clin Cancer Res. 2000 May;6(5):2012-20. Clin Cancer Res. 2000. PMID: 10815927 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters